Bandrone-Ibandronic Acid Bandrone is used for treatment and prevention of osteoporosis in postmenopausal women. The medicine contains bandronic acid and belongs to a class of medications known as bisphosphonate. It functions by preventing the breakdown of bone by bone cells known as osteoclasts. Supplied as: Available in 50 mg & 150 mg tablets & also as a 6 mg vial. Dosage: The medicine may be taken daily, but it is the only oral biphosphonate which is approved to be taken monthly. Overdose: Symptoms of overdose associated with the medicine includes stomach upset, gastrointestinal problems, hypocalcemiam and dyspepsia. Drug interactions: The medicine interacts with the following:
- Non-steroidal anti-inflammatory agents
- Not recommended for patients who are allergic to the medicine
- Not suitable for persons suffering from kidney problems
- Pregnant women must consult doctor before taking the course medicine. Appropriate usage of birth control is recommended
in section "Pharmaceutical Ointments"
View also products categories "Ointments"